
Bioextrax Investor Relations Material
Latest events

Q1 2025
Bioextrax

Q1 2025
20 May, 2025

Q4 2024
25 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Bioextrax
Access all reports
Bioextrax AB develops and commercializes a bio-extraction platform technology delivering high purity active ingredients from non-traditional sources with lower cost than traditional extraction methods like CO2. Bioextrax has developed specific patented and protected technology platforms to produce active pharmaceutical ingredients (APIs) such as Omega 3, polyunsaturated fatty acids, astaxanthin and squalene. Bioextrax AB is haedquartered in Lund, Sweden.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
BIOEX
Country
🇸🇪 Sweden